These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 4625517

  • 1. Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
    Kiev A, Güclü B, Kulkarni AS.
    Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517
    [No Abstract] [Full Text] [Related]

  • 2. Piperacetazine (Quide): a controlled evaluation of the elixir in chronic schizophrenic patients.
    Gallant DM, Bishop MP.
    Curr Ther Res Clin Exp; 1970 Jun; 12(6):387-9. PubMed ID: 4987346
    [No Abstract] [Full Text] [Related]

  • 3. Relative efficacy of butaperazine and chlorpromazine in acute schizophrenia.
    Gershon S, Hekimian LJ, Burdock EI, Park S, Floyd A.
    Curr Ther Res Clin Exp; 1970 Dec; 12(12):810-8. PubMed ID: 4396420
    [No Abstract] [Full Text] [Related]

  • 4. Piperacetazine and chlorpromazine: a comparison.
    Johnson AC, Kulkarni AS.
    Am J Psychiatry; 1973 May; 130(5):603-5. PubMed ID: 4144711
    [No Abstract] [Full Text] [Related]

  • 5. A double-blind comparison of the therapeutic efficacy of mesoridazine versus chlorpromazine.
    Freeman H, Oktem MR, Oktem N.
    Curr Ther Res Clin Exp; 1969 May; 11(5):263-70. PubMed ID: 4977397
    [No Abstract] [Full Text] [Related]

  • 6. Piperacetazine in chronic mental patients: clinical observations and new urine color test.
    Forrest FM, Forrest IS.
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):689-95. PubMed ID: 4629106
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of a new antipsychotic agent. Piperacetazine (quide).
    JAMA; 1971 Feb 01; 215(5):783-4. PubMed ID: 4395682
    [No Abstract] [Full Text] [Related]

  • 8. A controlled study of mesoridazine: an effective treatment for schizophrenia.
    McIndoo MV.
    South Med J; 1971 May 01; 64(5):592-6. PubMed ID: 4929612
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical evaluation of the TPN 12 (Sandoz) preparation in the treatment of mental disorders].
    Bukowczyk A, Korta B, Michalska M, Spisla B, Trzeciakowa O, Bryś J.
    Psychiatr Pol; 1971 May 01; 5(5):571-5. PubMed ID: 4400423
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
    Tetreault L, Bordeleau JM, Gauthier R, Vulpe M, Lapointe L.
    Dis Nerv Syst; 1969 Feb 01; 30(2):Suppl:74-84. PubMed ID: 4886994
    [No Abstract] [Full Text] [Related]

  • 12. Quide vs. Mellaril in chronic schizophrenic patients.
    Gallant DM, Bishop MP.
    Curr Ther Res Clin Exp; 1972 Jan 01; 14(1):10-6. PubMed ID: 4621558
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Piperacetazine (quide tablets).
    Clin Pharmacol Ther; 1969 Jan 01; 10(5):749-54. PubMed ID: 5808467
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.
    Zwanikken GJ.
    Psychiatr Neurol Neurochir; 1973 Jan 01; 76(2):83-92. PubMed ID: 4573494
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.